| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 56 |
| 1 | METHOTREXATE | 51 |
| 2 | FLUOROURACIL | 10 |
| 3 | FLUOROURACIL CREAM, 0.5% | 10 |
| 4 | PANITUMUMAB | 10 |
| 5 | BEVACIZUMAB | 7 |
| 6 | OXALIPLATIN | 7 |
| 7 | NIVOLUMAB | 6 |
| 8 | PEMBROLIZUMAB | 6 |
| 9 | CABOZANTINIB | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FUTIBATINIB | 1 | 0.0045 |
| 1 | TOVORAFENIB | 1 | 0.0031 |
| 2 | FRUQUINTINIB | 5 | 0.0013 |
| 3 | SELUMETINIB | 2 | 0.0012 |
| 4 | PANITUMUMAB | 10 | 0.0006 |
| 5 | TRABECTEDIN | 1 | 0.0004 |
| 6 | CICLOPIROX | 1 | 0.0004 |
| 7 | CHORIOGONADOTROPIN ALFA | 1 | 0.0004 |
| 8 | PATISIRAN | 1 | 0.0004 |
| 9 | SELINEXOR | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 1 | Gonadotropin [EPC] | 1 | 0.0005 |
| 2 | Nuclear Export Inhibitor [EPC] | 3 | 0.0003 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 10 | 0.0002 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 12 | 0.0001 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 51 | 0.0001 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 18 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Platinum-based Drug [EPC] | 11 | 0.0000 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 7 | 0.0000 |